Neuropsychiatric symptoms (NPS) are common in hereditary ataxias as a part of the cerebellar cognitive affective syndrome. In Friedreich ataxia (FRDA), one of the most common hereditary ataxias, depressive symptoms were previously reported, but little is known about other NPS. We aimed to study the presence and severity of a broad range of NPS in individuals with FRDA and assess the relationship between the NPS and the disease severity, cognition, and quality of life and to examine the concordance between the NPS reported by the patients and by their informants. Mild Behavioral Impairment Checklist (MBI-C), a questionnaire designed for screening NPS in the early stages of neurodegenerative diseases, was administered to informants of individuals with FRDA and healthy controls and to people with FRDA themselves. Compared to healthy controls, patients with FRDA scored significantly higher in the total MBI-C score, emotion dysregulation domain (corresponding to depression and anxiety), and decreased motivation domain. When assessed by caregiver, the total MBI-C score and several NPS domains correlated with activities of daily living. Only psychotic symptoms were related to ataxia severity and general cognition. When endorsed by patients, only the relation between few MBI-C domains and quality of life was observed. We found slight to moderate agreement between informant-rated and patient-rated scores. NPS, particularly emotion dysregulation and decreased motivation, are common and clinically relevant in FRDA and should receive more attention due to their potential impact on quality of life and the possibility of therapeutic intervention.

Center of Hereditary Ataxias Department of Neurology 2nd Faculty of Medicine and Motol University Hospital Charles University Prague Czech Republic

Center of Hereditary Ataxias Department of Pediatric Neurology 2nd Faculty of Medicine and Motol University Hospital Charles University Prague Czech Republic

Edson College of Nursing and Health Innovation Arizona State University Phoenix AZ USA

Women's Operational Military Exposure Network Center of Excellence VA Palo Alto Health Care System Palo Alto CA USA

Zobrazit více v PubMed

Schmahmann, J. The cerebellar cognitive affective syndrome. PubMed DOI

Argyropoulos, G. P. D. et al. The cerebellar cognitive affective/schmahmann syndrome: A task force paper. PubMed PMC

Abderrakib, A., Ligot, N. & Naeije, G. Cerebellar cognitive affective syndrome after acute cerebellar stroke. PubMed PMC

Levisohn, L., Cronin-Golomb, A. & Schmahmann, J. D. Neuropsychological consequences of cerebellar tumour resection in children. PubMed DOI

Kronemer, S. I. et al. Neuropsychiatric symptoms as a reliable phenomenology of cerebellar ataxia. PubMed DOI PMC

Cook, A. & Giunti, P. Friedreich’s ataxia: Clinical features, pathogenesis and management. PubMed PMC

Nieto, A. et al. Cognition in Friedreich Ataxia. PubMed DOI

Mantovan, M. C. et al. Exploring mental status in Friedreich’s ataxia: A combined neuropsychological, behavioral and neuroimaging study. PubMed

Sayah, S. et al. Personality and neuropsychological profiles in Friedreich ataxia. PubMed DOI

Schmahmann, J. D., Pierce, S., MacMore, J. & L’Italien, G. J. Development and validation of a patient-reported outcome measure of Ataxia. PubMed DOI

Schmitz-Hübsch, T. et al. Depression comorbidity in spinocerebellar ataxia. PubMed DOI

von Eichel, H. et al. Neuropsychiatric symptoms in Parkinson’s Disease patients are Associated with reduced health-related quality of life and increased caregiver Burden. PubMed PMC

Karttunen, K. et al. Neuropsychiatric symptoms and quality of life in patients with very mild and mild Alzheimer’s disease. PubMed DOI

Chan, Y. C. Aripiprazole treatment for psychosis associated with Friedreich’s ataxia. PubMed DOI

Oruc, S., Gulseren, G., Kusbeci, O. Y., Yaman, M. & Gecici, O. Quetiapine treatment for psychosis in Friedreich’s ataxia. DOI

Salbenblatt, M. J., Buzan, R. D. & Dubovsky, S. L. Risperidone treatment for psychosis in end-stage Friedreich’s ataxia. PubMed DOI

Corben, L. A. et al. Clinical management guidelines for Friedreich ataxia: best practice in rare diseases. PubMed DOI PMC

Pérez-Flores, J., Hernández-Torres, A., Montón, F. & Nieto, A. Health-related quality of life and depressive symptoms in Friedreich ataxia. PubMed DOI

Nieto, A., Hernández-Torres, A., Pérez-Flores, J. & Montón, F. Depressive symptoms in Friedreich ataxia. PubMed DOI PMC

da Silva, C. B., Chevis, C. F., D’Abreu, A., Lopes-Cendes, I. & França, M. C. Fatigue is frequent and multifactorial in Friedreich’s ataxia. PubMed

Dogan, I. et al. Cognition in Friedreich’s ataxia: a behavioral and multimodal imaging study. PubMed DOI PMC

Hernández-Torres, A., Montón, F., Medler, H., De Nóbrega, S., Nieto, A. & É. & Longitudinal study of cognitive functioning in Friedreich’s Ataxia. PubMed DOI

Costabile, T. et al. Emotion recognition and psychological comorbidity in Friedreich’s ataxia. PubMed DOI

White, M., Lalonde, R. & Botez-Marquard, T. Neuropsychologic and neuropsychiatric characteristics of patients with Friedreich’s ataxia. PubMed DOI

Ganos, C., Schöttle, D., Zühlke, C. & Münchau, A. Psychosis complicating Friedreich Ataxia. PubMed DOI PMC

Zalesky, A. et al. Cerebello-cerebral connectivity deficits in Friedreich ataxia. PubMed DOI

Cummings, J. L. The neuropsychiatric inventory: Assessing psychopathology in dementia patients. PubMed DOI

Kaufer, D. I. et al. Validation of the NPI-Q, a brief clinical form of the neuropsychiatric inventory. PubMed DOI

Ismail, Z. et al. The mild behavioral impairment checklist (MBI-C): A rating scale for neuropsychiatric symptoms in Pre-dementia populations. PubMed DOI PMC

Ismail, Z. et al. Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment. PubMed DOI PMC

Mallo, S. C. et al. Assessing mild behavioral impairment with the mild behavioral impairment-checklist in people with mild cognitive impairment. PubMed DOI

Lang, S. et al. Mild behavioral impairment in Parkinson’s disease is associated with altered corticostriatal connectivity. PubMed PMC

Yoon, E. J. et al. Mild behavioral impairment is linked to worse cognition and brain atrophy in Parkinson disease. PubMed DOI PMC

Ramezani, M. et al. Association between BDNF Val66Met polymorphism and mild behavioral impairment in patients with Parkinson’s disease. PubMed PMC

Ferraro, P. M. et al. Mild behavioral impairment as a potential marker of predementia risk states in motor neuron diseases. PubMed DOI PMC

Ismail, Z. MBI test. Retrieved from https://mbitest.org/

McKinlay, A. et al. Neuropsychiatric problems in Parkinson’s disease: Comparisons between self and caregiver report. PubMed DOI

Muller, A. J. et al. Informant- and self-appraisals on the psychosis and Hallucinations Questionnaire (PsycH-Q) enhances detection of visual hallucinations in Parkinson’s Disease. PubMed DOI PMC

Schmitz-Hübsch, T. et al. Scale for the assessment and rating of ataxia. PubMed DOI

Nasreddine, Z. S. et al. The montreal cognitive assessment, MoCA: A brief screening tool for mild cognitive impairment. PubMed DOI

Bürk, K., Schulz, S. R. & Schulz, J. B. Monitoring progression in Friedreich ataxia: the use of clinical scales. PubMed DOI

Herdman, M. et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). PubMed DOI PMC

Matušková, V. et al. Neuropsychiatric symptoms as early manifestation of Alzheimer’s disease. DOI

RStudio, T. & RStudio RStudio: Integrated Development for R. PBC, Boston, MA URL http://www.rstudio.com/. (2020).

Reetz, K. et al. Nonataxia symptoms in Friedreich Ataxia: Report from the Registry of the European Friedreich’s Ataxia Consortium for Translational studies (EFACTS). PubMed DOI

Fichera, M. et al. Comorbidities in Friedreich ataxia: incidence and manifestations from early to advanced disease stages. PubMed DOI

Schneider, R. B., Iourinets, J. & Richard, I. H. Parkinson’s disease psychosis: Presentation, diagnosis and management. PubMed DOI

Matuskova, V. et al. Comparison between self- and informant‐rated versions of the mild behavioral impairment checklist in patients with mild cognitive impairment.

Karamazovova, S., Matuskova, V., Ismail, Z. & Vyhnalek, M. Neuropsychiatric symptoms in spinocerebellar ataxias and Friedreich ataxia. PubMed DOI

Fancellu, R. et al. Longitudinal study of cognitive and psychiatric functions in spinocerebellar ataxia types 1 and 2. PubMed DOI

Moriarty, A. et al. A longitudinal investigation into cognition and disease progression in spinocerebellar ataxia types 1, 2, 3, 6, and 7. PubMed PMC

Lo, R. Y. et al. Depression and clinical progression in spinocerebellar ataxias. PubMed DOI PMC